A citation-based method for searching scientific literature

W S Colucci, U Elkayam, D P Horton, W T Abraham, R C Bourge, A D Johnson, L E Wagoner, M M Givertz, C S Liang, M Neibaur, W H Haught, T H LeJemtel. N Engl J Med 2000
Times Cited: 696







List of co-cited articles
1177 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
818
56


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
38


Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Jonathan D Sackner-Bernstein, Hal A Skopicki, Keith D Aaronson. Circulation 2005
544
23

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
670
22

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
449
21

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial.
John B Kostis, Milton Packer, Henry R Black, Roland Schmieder, David Henry, Elliott Levy. Am J Hypertens 2004
354
19



Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.
Horng H Chen, Kevin J Anstrom, Michael M Givertz, Lynne W Stevenson, Marc J Semigran, Steven R Goldsmith, Bradley A Bart, David A Bull, Josef Stehlik, Martin M LeWinter,[...]. JAMA 2013
278
16

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
395
16

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
15

Natriuretic peptides.
E R Levin, D G Gardner, W K Samson. N Engl J Med 1998
15

A new natriuretic peptide in porcine brain.
T Sudoh, K Kangawa, N Minamino, H Matsuo. Nature 1988
15

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
John R Teerlink, Gad Cotter, Beth A Davison, G Michael Felker, Gerasimos Filippatos, Barry H Greenberg, Piotr Ponikowski, Elaine Unemori, Adriaan A Voors, Kirkwood F Adams,[...]. Lancet 2013
639
14

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
Lincoln R Potter, Andrea R Yoder, Darcy R Flora, Laura K Antos, Deborah M Dickey. Handb Exp Pharmacol 2009
309
13

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. Circulation 2013
12

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
J L Rouleau, M A Pfeffer, D J Stewart, D Isaac, F Sestier, E K Kerut, C B Porter, G Proulx, C Qian, A J Block. Lancet 2000
317
12


Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Ondrej Lisy, Brenda K Huntley, Daniel J McCormick, Paul A Kurlansky, John C Burnett. J Am Coll Cardiol 2008
125
12


Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
296
12

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
932
12


Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
S J Holmes, E A Espiner, A M Richards, T G Yandle, C Frampton. J Clin Endocrinol Metab 1993
270
12

Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
E G Bevan, J M Connell, J Doyle, H A Carmichael, D L Davies, A R Lorimer, G T McInnes. J Hypertens 1992
127
11


Natriuretic peptides in cardiovascular diseases: current use and perspectives.
Massimo Volpe, Speranza Rubattu, John Burnett. Eur Heart J 2014
151
11


Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
R J Cody, S A Atlas, J H Laragh, S H Kubo, A B Covit, K S Ryman, A Shaknovich, K Pondolfino, M Clark, M J Camargo. J Clin Invest 1986
773
10

Cardiac fibrosis in mice lacking brain natriuretic peptide.
N Tamura, Y Ogawa, H Chusho, K Nakamura, K Nakao, M Suda, M Kasahara, R Hashimoto, G Katsuura, M Mukoyama,[...]. Proc Natl Acad Sci U S A 2000
431
10

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Sarah Mangiafico, Lisa C Costello-Boerrigter, Ingrid A Andersen, Alessandro Cataliotti, John C Burnett. Eur Heart J 2013
156
10

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
10

Diuretic strategies in patients with acute decompensated heart failure.
G Michael Felker, Kerry L Lee, David A Bull, Margaret M Redfield, Lynne W Stevenson, Steven R Goldsmith, Martin M LeWinter, Anita Deswal, Jean L Rouleau, Elizabeth O Ofili,[...]. N Engl J Med 2011
836
9

Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
G Cotter, E Metzkor, E Kaluski, Z Faigenberg, R Miller, A Simovitz, O Shaham, D Marghitay, M Koren, A Blatt,[...]. Lancet 1998
330
9


Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Andrew J Burger, Darlene P Horton, Thierry LeJemtel, Jalal K Ghali, Guillermo Torre, George Dennish, Michael Koren, Jay Dinerman, Marc Silver, Mei L Cheng,[...]. Am Heart J 2002
211
9

Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.
Veselin Mitrovic, Hartmut Lüss, Klaus Nitsche, Kristin Forssmann, Erik Maronde, Katrin Fricke, Wolf-Georg Forssmann, Markus Meyer. Am Heart J 2005
68
13

Haemodynamic and clinical effects of ularitide in decompensated heart failure.
Veselin Mitrovic, Petar M Seferovic, Dejan Simeunovic, Arsen D Ristic, Milutin Miric, Valentin S Moiseyev, Zhanna Kobalava, Klaus Nitsche, Wolf-Georg Forssmann, Hartmut Lüss,[...]. Eur Heart J 2006
108
9

Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy.
Mitsuru Suwa, Yoshihiko Seino, Yoshikata Nomachi, Shinsuke Matsuki, Kazuteru Funahashi. Circ J 2005
91
9

Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Kazuomi Kario, Ningling Sun, Fu-Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang. Hypertension 2014
127
9

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
9

Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.
Horng H Chen, James F Glockner, John A Schirger, Alessandro Cataliotti, Margaret M Redfield, John C Burnett. J Am Coll Cardiol 2012
69
13

Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
J W Knowles, G Esposito, L Mao, J R Hagaman, J E Fox, O Smithies, H A Rockman, N Maeda. J Clin Invest 2001
225
9


2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
9

Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
Milton Packer, Christopher O'Connor, John J V McMurray, Janet Wittes, William T Abraham, Stefan D Anker, Kenneth Dickstein, Gerasimos Filippatos, Richard Holcomb, Henry Krum,[...]. N Engl J Med 2017
173
9

Furin-mediated processing of Pro-C-type natriuretic peptide.
Chengliang Wu, Faye Wu, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2003
141
8

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.
S W John, J H Krege, P M Oliver, J R Hagaman, J B Hodgin, S C Pang, T G Flynn, O Smithies. Science 1995
491
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.